Global Japanese Encephalitis Vaccines Market Insights and Forecast to 2028
Summary:
Market Analysis and Insights: Global Japanese Encephalitis Vaccines Market
Epidemic encephalitis (JE) is a disease spreads through mosquito bites. Symptoms usually take 5-15 days to develop and include fever, headache, vomiting, confusion, and difficulty moving. The major form of the disease is encephalitis, and less severe forms such as aseptic meningitis or simple fever syndrome with headache are also frequent. The mortality rate of Japanese encephalitis is high, and sequelae are very common, especially among children (up to 50%). Prevention is possible through the use of inactivated vaccines.
Due to the COVID-19 pandemic, the global Japanese Encephalitis Vaccines market size is estimated to be worth US$ 220.9 million in 2022 and is forecast to a readjusted size of US$ 300.3 million by 2028 with a CAGR of 5.3% during the review period. Fully considering the economic change by this health crisis, Attenuated Vaccines accounting for % of the Japanese Encephalitis Vaccines global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Adults segment is altered to an % CAGR throughout this forecast period.
China Japanese Encephalitis Vaccines market size is valued at US$ million in 2021, while the US and Europe Japanese Encephalitis Vaccines are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Japanese Encephalitis Vaccines landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Japanese Encephalitis Vaccines include Sanofi Pasteur, GlaxoSmithKline, Bharat Biotech, China National Biotec Group and Valneva Products, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Market Segments
The authors of this research report have explored the key segments: Type and Application. The report offers an in-depth breakdown of type and application segments and their sub-segments. The lucrativeness and growth potential have been looked into by the industry experts in this report. This section of the report also provides sales and revenue forecast data by type and application segments based on sales, price, and revenue for the period 2017-2028. The specialists, to broaden the understanding of the users, have done value chain and raw material analysis in this section.
Segment by Type
Attenuated Vaccines
Inactivated Vaccines
Segment by Application
Adults
Children
Consequence of Covid-19 Pandemic
The authors of this study have enlightened the readers on the rise and effect of the Covid-19 outbreak on the development. They have investigated the changes brought about in the demand/supply side, consumption, supply chain, and sales/manufacturing. The readers will get familiar with the measures that have helped the key players to bring the Japanese Encephalitis Vaccines market back to the pre-covid levels.
Trends & Prospects
In this segment of the report, the specialists have delved into the key growth opportunities that are likely to emerge. This will aid the key players to simplify complex issues related to business and frame future strategies to compete in this competitive environment. This section will certainly assist the players to boldly position their business.
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Competitive Outlook
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and share analysis of the prominent players are also provided in this section. They have also provided reliable sales and revenue data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Sanofi Pasteur
GlaxoSmithKline
Bharat Biotech
China National Biotec Group
Valneva Products
Frequently Asked Questions
Which is the most lucrative product segment in the Japanese Encephalitis Vaccines market?
Which are the prominent strategies of the Japanese Encephalitis Vaccines market players?
Which factors are increasing the competition in the Japanese Encephalitis Vaccines market?
Which are the recommendations provided by the Japanese Encephalitis Vaccines industry experts?
Which region will witness rewarding growth during the forecast period?
What factors will curb the Japanese Encephalitis Vaccines market growth?
Which product segment will register the fastest growth rate in the Japanese Encephalitis Vaccines market?
Which emerging trends will impact the Japanese Encephalitis Vaccines market growth?
Which are the high-impact rendering factors in the Japanese Encephalitis Vaccines market?
Which companies will maintain their lead on the Japanese Encephalitis Vaccines market?
Table of Contents
1 Study Coverage
1.1 Japanese Encephalitis Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Japanese Encephalitis Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Attenuated Vaccines
1.2.3 Inactivated Vaccines
1.3 Market by Application
1.3.1 Global Japanese Encephalitis Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Adults
1.3.3 Children
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Japanese Encephalitis Vaccines Sales Estimates and Forecasts 2017-2028
2.2 Global Japanese Encephalitis Vaccines Revenue Estimates and Forecasts 2017-2028
2.3 Global Japanese Encephalitis Vaccines Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Japanese Encephalitis Vaccines Sales by Region
2.4.1 Global Japanese Encephalitis Vaccines Sales by Region (2017-2022)
2.4.2 Global Sales Japanese Encephalitis Vaccines by Region (2023-2028)
2.5 Global Japanese Encephalitis Vaccines Revenue by Region
2.5.1 Global Japanese Encephalitis Vaccines Revenue by Region (2017-2022)
2.5.2 Global Japanese Encephalitis Vaccines Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Japanese Encephalitis Vaccines Sales by Manufacturers
3.1.1 Global Top Japanese Encephalitis Vaccines Manufacturers by Sales (2017-2022)
3.1.2 Global Japanese Encephalitis Vaccines Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Japanese Encephalitis Vaccines in 2021
3.2 Global Japanese Encephalitis Vaccines Revenue by Manufacturers
3.2.1 Global Japanese Encephalitis Vaccines Revenue by Manufacturers (2017-2022)
3.2.2 Global Japanese Encephalitis Vaccines Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Japanese Encephalitis Vaccines Revenue in 2021
3.3 Global Japanese Encephalitis Vaccines Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Japanese Encephalitis Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Japanese Encephalitis Vaccines Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Japanese Encephalitis Vaccines Sales by Type
4.1.1 Global Japanese Encephalitis Vaccines Historical Sales by Type (2017-2022)
4.1.2 Global Japanese Encephalitis Vaccines Forecasted Sales by Type (2023-2028)
4.1.3 Global Japanese Encephalitis Vaccines Sales Market Share by Type (2017-2028)
4.2 Global Japanese Encephalitis Vaccines Revenue by Type
4.2.1 Global Japanese Encephalitis Vaccines Historical Revenue by Type (2017-2022)
4.2.2 Global Japanese Encephalitis Vaccines Forecasted Revenue by Type (2023-2028)
4.2.3 Global Japanese Encephalitis Vaccines Revenue Market Share by Type (2017-2028)
4.3 Global Japanese Encephalitis Vaccines Price by Type
4.3.1 Global Japanese Encephalitis Vaccines Price by Type (2017-2022)
4.3.2 Global Japanese Encephalitis Vaccines Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Japanese Encephalitis Vaccines Sales by Application
5.1.1 Global Japanese Encephalitis Vaccines Historical Sales by Application (2017-2022)
5.1.2 Global Japanese Encephalitis Vaccines Forecasted Sales by Application (2023-2028)
5.1.3 Global Japanese Encephalitis Vaccines Sales Market Share by Application (2017-2028)
5.2 Global Japanese Encephalitis Vaccines Revenue by Application
5.2.1 Global Japanese Encephalitis Vaccines Historical Revenue by Application (2017-2022)
5.2.2 Global Japanese Encephalitis Vaccines Forecasted Revenue by Application (2023-2028)
5.2.3 Global Japanese Encephalitis Vaccines Revenue Market Share by Application (2017-2028)
5.3 Global Japanese Encephalitis Vaccines Price by Application
5.3.1 Global Japanese Encephalitis Vaccines Price by Application (2017-2022)
5.3.2 Global Japanese Encephalitis Vaccines Price Forecast by Application (2023-2028)
6 North America
6.1 North America Japanese Encephalitis Vaccines Market Size by Type
6.1.1 North America Japanese Encephalitis Vaccines Sales by Type (2017-2028)
6.1.2 North America Japanese Encephalitis Vaccines Revenue by Type (2017-2028)
6.2 North America Japanese Encephalitis Vaccines Market Size by Application
6.2.1 North America Japanese Encephalitis Vaccines Sales by Application (2017-2028)
6.2.2 North America Japanese Encephalitis Vaccines Revenue by Application (2017-2028)
6.3 North America Japanese Encephalitis Vaccines Market Size by Country
6.3.1 North America Japanese Encephalitis Vaccines Sales by Country (2017-2028)
6.3.2 North America Japanese Encephalitis Vaccines Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Japanese Encephalitis Vaccines Market Size by Type
7.1.1 Europe Japanese Encephalitis Vaccines Sales by Type (2017-2028)
7.1.2 Europe Japanese Encephalitis Vaccines Revenue by Type (2017-2028)
7.2 Europe Japanese Encephalitis Vaccines Market Size by Application
7.2.1 Europe Japanese Encephalitis Vaccines Sales by Application (2017-2028)
7.2.2 Europe Japanese Encephalitis Vaccines Revenue by Application (2017-2028)
7.3 Europe Japanese Encephalitis Vaccines Market Size by Country
7.3.1 Europe Japanese Encephalitis Vaccines Sales by Country (2017-2028)
7.3.2 Europe Japanese Encephalitis Vaccines Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Japanese Encephalitis Vaccines Market Size by Type
8.1.1 Asia Pacific Japanese Encephalitis Vaccines Sales by Type (2017-2028)
8.1.2 Asia Pacific Japanese Encephalitis Vaccines Revenue by Type (2017-2028)
8.2 Asia Pacific Japanese Encephalitis Vaccines Market Size by Application
8.2.1 Asia Pacific Japanese Encephalitis Vaccines Sales by Application (2017-2028)
8.2.2 Asia Pacific Japanese Encephalitis Vaccines Revenue by Application (2017-2028)
8.3 Asia Pacific Japanese Encephalitis Vaccines Market Size by Region
8.3.1 Asia Pacific Japanese Encephalitis Vaccines Sales by Region (2017-2028)
8.3.2 Asia Pacific Japanese Encephalitis Vaccines Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Japanese Encephalitis Vaccines Market Size by Type
9.1.1 Latin America Japanese Encephalitis Vaccines Sales by Type (2017-2028)
9.1.2 Latin America Japanese Encephalitis Vaccines Revenue by Type (2017-2028)
9.2 Latin America Japanese Encephalitis Vaccines Market Size by Application
9.2.1 Latin America Japanese Encephalitis Vaccines Sales by Application (2017-2028)
9.2.2 Latin America Japanese Encephalitis Vaccines Revenue by Application (2017-2028)
9.3 Latin America Japanese Encephalitis Vaccines Market Size by Country
9.3.1 Latin America Japanese Encephalitis Vaccines Sales by Country (2017-2028)
9.3.2 Latin America Japanese Encephalitis Vaccines Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Japanese Encephalitis Vaccines Market Size by Type
10.1.1 Middle East and Africa Japanese Encephalitis Vaccines Sales by Type (2017-2028)
10.1.2 Middle East and Africa Japanese Encephalitis Vaccines Revenue by Type (2017-2028)
10.2 Middle East and Africa Japanese Encephalitis Vaccines Market Size by Application
10.2.1 Middle East and Africa Japanese Encephalitis Vaccines Sales by Application (2017-2028)
10.2.2 Middle East and Africa Japanese Encephalitis Vaccines Revenue by Application (2017-2028)
10.3 Middle East and Africa Japanese Encephalitis Vaccines Market Size by Country
10.3.1 Middle East and Africa Japanese Encephalitis Vaccines Sales by Country (2017-2028)
10.3.2 Middle East and Africa Japanese Encephalitis Vaccines Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Sanofi Pasteur
11.1.1 Sanofi Pasteur Corporation Information
11.1.2 Sanofi Pasteur Overview
11.1.3 Sanofi Pasteur Japanese Encephalitis Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Sanofi Pasteur Japanese Encephalitis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi Pasteur Recent Developments
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Corporation Information
11.2.2 GlaxoSmithKline Overview
11.2.3 GlaxoSmithKline Japanese Encephalitis Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 GlaxoSmithKline Japanese Encephalitis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GlaxoSmithKline Recent Developments
11.3 Bharat Biotech
11.3.1 Bharat Biotech Corporation Information
11.3.2 Bharat Biotech Overview
11.3.3 Bharat Biotech Japanese Encephalitis Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Bharat Biotech Japanese Encephalitis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bharat Biotech Recent Developments
11.4 China National Biotec Group
11.4.1 China National Biotec Group Corporation Information
11.4.2 China National Biotec Group Overview
11.4.3 China National Biotec Group Japanese Encephalitis Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 China National Biotec Group Japanese Encephalitis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 China National Biotec Group Recent Developments
11.5 Valneva Products
11.5.1 Valneva Products Corporation Information
11.5.2 Valneva Products Overview
11.5.3 Valneva Products Japanese Encephalitis Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Valneva Products Japanese Encephalitis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Valneva Products Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Japanese Encephalitis Vaccines Industry Chain Analysis
12.2 Japanese Encephalitis Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Japanese Encephalitis Vaccines Production Mode & Process
12.4 Japanese Encephalitis Vaccines Sales and Marketing
12.4.1 Japanese Encephalitis Vaccines Sales Channels
12.4.2 Japanese Encephalitis Vaccines Distributors
12.5 Japanese Encephalitis Vaccines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Japanese Encephalitis Vaccines Industry Trends
13.2 Japanese Encephalitis Vaccines Market Drivers
13.3 Japanese Encephalitis Vaccines Market Challenges
13.4 Japanese Encephalitis Vaccines Market Restraints
14 Key Findings in The Global Japanese Encephalitis Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets